Hoosier Oncology Group is very pleased to announce that Christopher A. Fausel, PharmD, MHA, BCOP, was appointed Chairman of the Board of Directors on July 31, 2013.

Dr. Fausel is the Clinical Manager of Oncology Pharmacy at the Indiana University Simon Cancer Center (IUSCC) in Indianapolis. Read More

The Hoosier Oncology Group is proud to be among the major contributors acknowledged in House Concurrent Resolution No. 44 of the State of Indiana General Assembly, honoring and recognizing the contributions of those Hoosiers who have helped fight the War on Cancer as cancer researchers or as patients serving as research participants.  This recognition is shared with our colleagues at the Indiana Cancer Consortium, Indiana University Simon Cancer Center, the Great Lakes Division of the American Cancer Society, Purdue University Cancer Center and Eli Lilly and Company. Read More

IU Simon Cancer Center breast cancer oncologist George Sledge, MD, is featured in the Discovery Channel documentary “Getting Personal: The Shifting Landscape of Cancer Care.”

New research is shedding light on the genetic causes of cancer, as well as the molecular make-up of individual cancers, paving the path for more effective therapies and more personalized “targeted” treatments. Read More

Dr. Daniela Matei received the Research Frontiers Trailblazer Award for her discoveries related to the biology of ovarian cancer at the second annual Research Day conference.

The Trailblazer award honors outstanding IUPUI researchers who are “showing great promise in becoming nationally and internationally known for their accomplishments in advancing the frontiers of knowledge.” Read More

Hoosier Oncology is pleased to announce that study LUN05-99 – “Paclitaxel plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer (SCLC):
A Safety, Feasibility and Efficacy Study” has been accepted by the Journal of Thoracic Oncology. Congratulations to Dr. Jalal and the entire team. Read More

We are pleased to announce that LUN-116 abstract has been published in the November 2010 issue of the Journal of Thoracic Oncology. Congratulations to Dr. Hanna and team!

Click here to review the abstract online. Read More

ASCO President, Dr. George W. Sledge, was among the clinician, government and industry leaders selected to testify before the President’s Cancer Panel in Boston on September 22, 2010. The meeting, titled, “The Future of Cancer Research: Accelerating Scientific Innovation,” focused on assessing the past 40 years of cancer research and exploring potential future enhancements and advances in biomedical science. Read More

George Sledge, M.D., can add yet one more title to his long list of impressive credentials and titles: President of the American Society of Clinical Oncology (ASCO). Dr. Sledge is most known for his ground-breaking work in breast cancer research, with a specific interest in the use of angiogenesis blockers, or disruption of the blood supply, in the treatment of breast cancer. Read More